Short-term and long-term evaluation of selective serotonin reuptake inhibitors in the treatment of panic disorder: Fluoxetine vs citalopram

Human Psychopharmacology

Volumn 14, Issue 6, 1999, Pages 435-440

  Amore, Mario ^a   Magnani, Katia ^a   Cerisoli, Marziano ^a   Ferrari, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Citalopram; Fluoxetine; Long term treatment; Panic disorder

Indexed keywords

CITALOPRAM; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AGITATION; AGORAPHOBIA; ANTICIPATION; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; NAUSEA; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION;

EID: 0032883928     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199908)14:6<435::AID-HUP109>3.0.CO;2-B     Document Type: Article

References (38)

1. Argyle, N., Deltito, J., Allerup, P., Maier, W., Albus, M., Nutzinger, D., Rasmussen, S., Ayuso, J. L. and Bech, P. (1991). The Panic-Associated Symptom Scale: measuring the severity of panic disorder. Acta Psychiatrica Scandinavica, 83, 20-26.
2. Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W. and Gergel, I. P. (1998). Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. American Journal of Psychiatry, 155, 36-42.
3. Baumel, B., Bielski, R., Carmen, J., Hegel, M., Houck, C., Linden, R., Nakra, B., Ota, K., Pohl, R. and Wolkow, R. (1996). Double-blind comparison of sertraline and placebo in patients with panic disorder. Poster presented at the 20th Collegium Internationale Neuro-Psychopharmacologicum. Melbourne, Australia.
4. Black, D. W., Wesner, R., Bowers, W. and Gabel, J. (1993). A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry, 50, 44-50.
5. Boyer, W. (1995). Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International Clinical Psychopharmacology, 10, 45-49.
6. Bystritsky, A., Rosen, R. M., Murphy, K. J., Bohn, P., Keys, S. A. and Vapnik, T. (1995). Double-blind pilot trial of desipramine versus fluoxetine in panic patients. Anxiety, 1, 287-290.
7. Charney, D. S., Woods, S. W., Goodman, W. K. and Heninger, G. R. (1987). Serotonin function in anxiety, II: effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology, 92, 14-24.
8. Den Boer, J. A. and Westenberg, H. G. M. (1998). Effect of serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. International Clinical Psychopharmacology, 3, 59-74.
9. Den Boer, J. A., Westenberg, H. G. M., Kamerbeek, W. D. J., Verhoeven, W. M. A. and Kahn, R. S. (1987). Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21-32.
10. Dunbar, G., Steiner, M. and Oakes, R. et al. (1995). A fixed dose study of paroxetine and placebo in the treatment of panic disorder. Poster presented at the VIIIth Congress of the European College of Neuropsychopharmacology, Venice, Italy.
11. Gloger, S., Grunhaus, L., Birmacher, B. and Troudart, T. (1981). Treatment of spontaneous panic attacks with clomipramine. American Journal of Psychiatry, 138, 1215-1217.
12. Gorman, J. M. and Wolkow, R. (1994). Sertraline as a treatment for panic disorder (abstract). Neuropsychopharmacology, 10(35 part 2), 1975.
13. Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Goetz, D., Campeas, R. B., Fyer, M. R., Davies, S. O. and Klein, D. F. (1987). An open trial of fluoxetine in the treatment of panic attacks. Journal of Clinical Psychopharmacology, 7, 329-332.
14. Hoehn-Saric, R., McCleod, D. R. and Hipsley, P. A. (1993). Effect of fluvoxamine on panic disorder. Journal of Clinical Psychopharmacology, 13, 321-326.
15. Humble, M. and Wistedt, B. (1992). Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. International Clinical Psychopharmacology, 6(suppl. 5), 21-39.
16. Jefferson, J. W. (1997). Antidepressants in panic disorder. Journal of Clinical Psychiatry, 58(suppl. 2), 20-24.
17. Johnson, M. R., Lydiard, R. B. and Ballenger, J. C. (1995). Panic disorder. Pathophysiology and drug treatment. Drugs, 49, 328-344.
18. Kahn, R. J., McNair, D. M., Lipman, R. S. and Covi, L. (1986). Imipramine and clordiazepoxide in depressive and anxiety disorders II: efficacy in anxious out-patients. Archives of General Psychiatry, 43, 79-85.
19. Keller, M. B., Yonkers, K. A., Warshaw, M. G., Pratt, L. A., Gollan, J. K., Massion, A. O., White, K., Swartz, A. R., Reich, J. and Lavori, P. W. (1994). Remission and relapse in subjects with panic disorder and panic with agoraphobia. Journal of Nervous and Mental Disease, 182(5), 290-296.
20. Lecrubier, Y., Bakker, A., Dunbar, G. and Judge, R. (1997a). A comparison of paroxetine clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica, 95, 145-152.
21. Lecrubier Y, Judge R, and the Collaborative Paroxetine Panic Study Investigators (1997b). Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatrica Scandinavica, 95, 153-160.
22. Lepola, U., Leinonen, E., Turtonen, J. and Pertinen, J. (1994). The effect of citalopram in panic disorder and agoraphobia. Nord Journal of Psychiatry, 48(1), 13-17.
23. Lepola, U., Wade, A. G., Leinonen, E. V., Koponen, H. J., Frazer, J., Sjodin, I., Penttinen, J. T., Pedersen, T. and Lehto, H. J. (1998). A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. Journal of Clinical Psychiatry, 59, 528-534.
24. Louie, A. K., Lewis, T. B. and Lannon, R. A. (1993). Use of low-dose fluoxetine in major depression and panic disorder. Journal of Clinical Psychiatry, 54, 435-438.
25. Lydiard, R. B., Pollack, M. H., Judge, R., Michelson, D. and Tamura, R. (1997). Fluoxetine in panic disorder: a placebo-controlled study. Presented at the 10th Congress European College of Neuropsychopharmacology, Vienna.
26. Norusis, M. J. (1994). SPSS/PC+ Advanced Statistics, Version 6.0. SPSS Inc., Chicago.
27. Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K. and Maniiche, P. M. (1995). Paroxetine in the treatment of panic disorder. British Journal of Psychiatry, 167, 374-379.
28. SAS (1990). SAS User's Guide; Statistics, Version 6.04. SAS Institute Inc, Cary, NC.
29. Schneier, F., Liebowitz, M. R., Davies, S. O., Faierbanks, J., Hollander, E., Campeas, R. and Klein, D. F. (1990). Fluoxetine in panic disorder. Journal of Clinical Psychopharmacology, 10, 119-121.
30. Sheehan, D. V. and Harnett-Sheehan, K. (1996). The role of SSRIs in panic disorder. Journal of Clinical Psychiatry, 57(suppl. 10), 51-58.
31. Sheehan, D. V., Zak, J. P., Miller, J. A. and Fanous, B. S. L. (1988). Panic disorder: the potential role of serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 49(suppl. 8), 30-36.
32. Solyom, L., Solyom, C. and Ledwidge, B. (1991). Fluoxetine in panic disorder. Canadian Journal of Psychiatry, 36, 378-380.
33. Stanton Glantz, A. (1987). Primer of Biostatistics. McGraw Hill, New York.
34. Steiner, M., Oakes, R., Gergel, I. P., Burnham, D. B. and Wheadon, D. E. (1995). A fixed dose study of paroxetine and placebo in the treatment of panic disorder. In New Research Program and Abstracts of the 148th Annual Meeting of the American Psychiatric Association, Abstract NR355, 150, Miami, FL.
35. Wade, A. G., Lepola, U., Koponen, H. J., Pedersen, V. and Pedersen, T. (1997). The effect of citalopram in panic disorder. British Journal of Psychiatry, 170, 549-553.
36. Westenberg, H. G. M. (1996). Developments in the drug treatment of panic disorder: what is the place of selective serotonin reuptake inhibitors? Journal of Affective Disorders, 40, 85-93.
37. Woods, S., Black, D., Brown, S., Asnis, G., Potkin, S., Hameedi, F. and Goddard, A. (1994). Fluvoxamine in the treatment of panic disorder in outpatients: a double-blind, placebo-controlled study. Neuropsychopharmacology, 10(suppl. 3), 103.
38. Yonkers, K. A., Zlotnick, C., Allsworth, J., Warshaw, M., Shea, T. and Keller, M. B. (1998). Is the course of Panic Disorder the same in women and men? The American Journal of Psychiatry, 155, 596-602.